Market Closed -
Nyse
04:00:02 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
93.59
USD
|
+0.60%
|
|
+1.72%
|
+12.08%
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,619
|
2,034
|
2,843
|
3,597
|
3,875
|
5,188
|
-
|
-
|
Enterprise Value (EV)
1 |
3,514
|
2,998
|
3,837
|
4,834
|
4,913
|
6,177
|
6,108
|
6,071
|
P/E ratio
|
17.2
x
|
-8.56
x
|
11.5
x
|
-
|
-
|
-
|
-
|
-
|
Yield
|
3%
|
3.89%
|
2.79%
|
2.32%
|
2.22%
|
1.75%
|
1.88%
|
1.99%
|
Capitalization / Revenue
|
0.78
x
|
0.78
x
|
0.83
x
|
0.83
x
|
0.99
x
|
1.28
x
|
1.21
x
|
1.16
x
|
EV / Revenue
|
1.05
x
|
1.15
x
|
1.13
x
|
1.12
x
|
1.25
x
|
1.53
x
|
1.42
x
|
1.36
x
|
EV / EBITDA
|
6.49
x
|
7.51
x
|
5.88
x
|
6.64
x
|
7.07
x
|
7.65
x
|
6.93
x
|
6.69
x
|
EV / FCF
|
25.6
x
|
16.9
x
|
61.9
x
|
-43.5
x
|
14
x
|
17.7
x
|
31.4
x
|
28.4
x
|
FCF Yield
|
3.9%
|
5.9%
|
1.62%
|
-2.3%
|
7.14%
|
5.65%
|
3.18%
|
3.52%
|
Price to Book
|
2.59
x
|
2.94
x
|
3
x
|
4.02
x
|
-
|
3.59
x
|
3.11
x
|
2.74
x
|
Nbr of stocks (in thousands)
|
57,783
|
56,462
|
56,724
|
56,299
|
55,937
|
55,431
|
-
|
-
|
Reference price
2 |
45.32
|
36.03
|
50.12
|
63.89
|
69.27
|
93.59
|
93.59
|
93.59
|
Announcement Date
|
11/4/19
|
11/23/20
|
11/8/21
|
11/7/22
|
11/6/23
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,337
|
2,614
|
3,409
|
4,321
|
3,931
|
4,042
|
4,293
|
4,453
|
EBITDA
1 |
541
|
399
|
652
|
728
|
695
|
807.8
|
881.8
|
907.3
|
EBIT
1 |
394
|
242
|
492
|
583
|
553
|
655.2
|
723.1
|
770.5
|
Operating Margin
|
11.81%
|
9.26%
|
14.43%
|
13.49%
|
14.07%
|
16.21%
|
16.84%
|
17.3%
|
Earnings before Tax (EBT)
1 |
255
|
-33
|
406
|
335
|
451
|
534.7
|
611.5
|
677
|
Net income
|
157
|
-238
|
250
|
209
|
445
|
-
|
-
|
-
|
Net margin
|
4.7%
|
-9.1%
|
7.33%
|
4.84%
|
11.32%
|
-
|
-
|
-
|
EPS
|
2.630
|
-4.210
|
4.340
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
137
|
177
|
62
|
-111
|
351
|
349
|
194.5
|
214
|
FCF margin
|
4.11%
|
6.77%
|
1.82%
|
-2.57%
|
8.93%
|
8.63%
|
4.53%
|
4.81%
|
FCF Conversion (EBITDA)
|
25.32%
|
44.36%
|
9.51%
|
-
|
50.5%
|
43.2%
|
22.06%
|
23.59%
|
FCF Conversion (Net income)
|
87.26%
|
-
|
24.8%
|
-
|
78.88%
|
-
|
-
|
-
|
Dividend per Share
2 |
1.360
|
1.400
|
1.400
|
1.480
|
1.540
|
1.641
|
1.757
|
1.861
|
Announcement Date
|
11/4/19
|
11/23/20
|
11/8/21
|
11/7/22
|
11/6/23
|
-
|
-
|
-
|
Fiscal Period: September |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
904
|
968
|
1,092
|
1,149
|
1,112
|
965
|
1,033
|
968
|
965
|
958
|
1,045
|
1,024
|
1,008
|
1,014
|
1,167
|
EBITDA
1 |
143
|
162
|
191
|
197
|
178
|
142
|
170
|
189
|
194
|
181
|
198.1
|
203.2
|
203.1
|
200.2
|
233.9
|
EBIT
1 |
101
|
123
|
155
|
162
|
143
|
108
|
134
|
153
|
158
|
140
|
160.6
|
165
|
164.9
|
161.2
|
194.9
|
Operating Margin
|
11.17%
|
12.71%
|
14.19%
|
14.1%
|
12.86%
|
11.19%
|
12.97%
|
15.81%
|
16.37%
|
14.61%
|
15.37%
|
16.12%
|
16.36%
|
15.9%
|
16.71%
|
Earnings before Tax (EBT)
1 |
66
|
-93
|
147
|
152
|
129
|
84
|
110
|
130
|
127
|
-
|
137.3
|
132.6
|
140.8
|
-
|
-
|
Net income
|
29
|
-89
|
107
|
97
|
94
|
54
|
75
|
82
|
234
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
3.21%
|
-9.19%
|
9.8%
|
8.44%
|
8.45%
|
5.6%
|
7.26%
|
8.47%
|
24.25%
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.5000
|
-1.570
|
1.840
|
-
|
-
|
0.9300
|
1.290
|
1.430
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.3500
|
0.3700
|
0.3700
|
0.3700
|
0.3700
|
0.3700
|
-
|
0.4000
|
-
|
-
|
0.3943
|
0.3943
|
0.4337
|
0.4337
|
0.4337
|
Announcement Date
|
11/8/21
|
1/31/22
|
5/2/22
|
8/8/22
|
11/7/22
|
2/9/23
|
5/8/23
|
8/7/23
|
11/6/23
|
2/5/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: September |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
895
|
964
|
994
|
1,237
|
1,038
|
989
|
920
|
883
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.654
x
|
2.416
x
|
1.525
x
|
1.699
x
|
1.494
x
|
1.224
x
|
1.043
x
|
0.9735
x
|
Free Cash Flow
1 |
137
|
177
|
62
|
-111
|
351
|
349
|
195
|
214
|
ROE (net income / shareholders' equity)
|
21.4%
|
13.9%
|
34.8%
|
39%
|
28.1%
|
27.2%
|
26.7%
|
25.8%
|
ROA (Net income/ Total Assets)
|
7.36%
|
4.07%
|
9.37%
|
10.5%
|
8.53%
|
9.92%
|
10.5%
|
10.9%
|
Assets
|
2,133
|
-5,848
|
2,668
|
1,983
|
5,218
|
-
|
-
|
-
|
Book Value Per Share
2 |
17.50
|
12.20
|
16.70
|
15.90
|
-
|
26.10
|
30.10
|
34.20
|
Cash Flow per Share
2 |
6.140
|
6.660
|
4.520
|
1.760
|
10.50
|
9.120
|
9.880
|
10.30
|
Capex
1 |
224
|
200
|
195
|
211
|
244
|
255
|
285
|
294
|
Capex / Sales
|
6.71%
|
7.65%
|
5.72%
|
4.88%
|
6.21%
|
6.31%
|
6.64%
|
6.6%
|
Announcement Date
|
11/4/19
|
11/23/20
|
11/8/21
|
11/7/22
|
11/6/23
|
-
|
-
|
-
|
Last Close Price
93.59
USD Average target price
95.33
USD Spread / Average Target +1.86% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.08% | 5.19B | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|